Test
334 articles
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
Let’s Win Announces Let’s Learn Webinar Series
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our webinars!
Safety and Effectiveness of a New Drug for Advanced Pancreatic Cancer
Researchers are testing dose safety and effectiveness of a new drug for pancreatic cancer, in combination with gemcitabine.
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
Let’s Win: Innovative Online Community Offers Guidance to Patients With Pancreatic Cancer and Their Families
The ASCO Post, a news publication of the American Society of Clinical Oncology, features Let’s Win and its mission to help pancreatic cancer patients.
mRNA Vaccine Shows Sustained Immune Activity in Small Patient Group
Dr. Vinod Balachandran reports notable antitumor response in about half to the patients in his mRNA vaccine clinical trial.
What You Should Know About Pancreatic Cysts
Dr. V. Raman Muthusamy explains the difference between pancreatic cysts and pancreatic cancer. Learn about different types of pancreatic cysts and which may develop cancer.
Eighteen Important Words to Know if You Have Pancreatic Cancer
When you start pancreatic cancer treatment it seems like everyone is speaking a language you don’t know. Here are 18 important words to help you along.
Looking Back at the Year in Research: 2019
Research highlights of 2019 include: approval of a PARP inhibitor, artificial intelligence to diagnose pancreatic cysts, and updated radiation guidelines.
Endurance, Resilience, and Tenacity
After his pancreatic cancer diagnosis, John Sanders went for a second opinion, which led to a more aggressive treatment plan.
When You Embrace the Enemy, It Changes Everything
Larry Clark describes how pancreatic cancer changed his retirement. He has pursued clinical trials as he faces recurring pancreatic cancer.
No Time To Lose
Eduardo Servin acted pretty quickly when he began itching all over and noticed that he was jaundiced. He believes this saved his life.
New Vaccine Harnesses Power Of the Lymph Nodes
A promising new vaccine targets KRAS, the most common mutation in pancreatic cancer. Dr. Shubham Pant provides an update.
Don’t Give Up
Joe Pearson responded so well to chemotherapy that even with a stage III tumor near a blood vessel he was able to have Whipple surgery.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?